In vivo characteristics of cationic liposomes as delivery vectors for gene therapy

Pharmaceutical Research

Volumn 19, Issue 11, 2002, Pages 1599-1605

  Audouy, S A L ^a   De Leij, L F M H ^a   Hoekstra, D ^a   Molema, G ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Biodistribution; Cationic liposomes; Gene therapy; Inflammation; Toxicity

Indexed keywords

CATION; DNA; LIPOSOME; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; COMPLEX FORMATION; DRUG DISTRIBUTION; DRUG FORMULATION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; IMMUNE RESPONSE; IN VIVO STUDY; INFLAMMATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PHARMACODYNAMICS; PRIORITY JOURNAL; REVIEW; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CATIONS; DRUG DELIVERY SYSTEMS; GENE THERAPY; HUMANS; LIPOSOMES;

EID: 0036844766     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020989709019     Document Type: Review

References (57)

1. M. Laitinen, J. Hartikainen, M. O. Hiltunen, J. Eranen, M. Kiviniemi, O. Narvanen, K. Makinen, H. Manninen, M. Syvanne, J. F. Martin, M. Laakso, and S. Yla-Herttuala. Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Hum. Gene Ther. 11:263-270 (2000).
2. P. L. Felgner, T. R. Gadek, M. Holm, R. Roman, H. W. Chan, M. Wenz, J. P. Northrop, G. M. Ringold, and M. Danielsen. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84:7413-7417 (1987).
3. S. Audouy and D. Hoekstra. Cationic lipid-mediated transfection in vitro and in vivo. Mol. Membr. Biol. 18:129-143 (2001).
4. D. Lew, S. E. Parker, T. Latimer, A. M. Abai, A. Kuwahara-Rundell, S. G. Doh, Z.-Y. Yang, D. Laface, S. H. Gromkowski, G. J. Nabel, M. Manthorpe, and J. Norman. Cancer gene therapy using plasmid DNA: Pharmacokinetic study of DNA following injection in mice. Hum. Gene Ther. 6:553-564 (1995).
5. N. Smyth Templeton, D. D. Lasic, P. M. Frederik, H. H. Strey, D. D. Roberts, and G. N. Pavlakis. Improved DNA: Liposome complexes for increased systemic delivery and gene expression. Nature Biotechnol. 15:647-652 (1997).
6. S. E. Parker, S. Ducharme, J. Norman, and C. J. Wheeler. Tissue distribution of the cytofectin component of a plasmid DNA/cationic lipid complex following intravenous administration in mice. Hum. Gene Ther. 8:393-401 (1997).
7. R. Niven, R. Pearlman, T. Wedeking, J. Mackeigan, P. Noker, L. Simpson-Herren, and J. G. Smith. Biodistribution of radiolabeled lipid-DNA complexes and DNA in mice. J. Pharm. Sci. 87:1292-1299 (1998).
8. J. W. McLean, E. A. Fox, P. Baluk, P. B. Bolton, A. Haskell, R. Pearlman, G. Thurston, E. Y. Umemoto, and D. McDonald. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am. J. Physiol. 273:H387-H404 (1997).
9. L. S. Uyechi, L. Gagne, G. Thurston, and F. C. J. Szoka. Mechanism of lipoplex gene delivery to mouse lung: Binding and internalization of fluorescent lipid and DNA components. Gene Ther. 8:828-836 (2001).
10. F. Liu, H. Qi, L. Huang, and D. Liu. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Ther. 4:517-523 (1997).
11. Y. K. Song, F. Liu, S. Chu, and D. Liu. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum. Gene Ther. 8:1585-1594 (1997).
12. N. Zhu, D. Liggitt, Y. Liu, and R. Debs. Systemic gene expression after intravenous DNA delivery into adult mice. Science 261:209-211 (1993).
13. Y. Liu, L. C. Mounkes, H. D. Liggit, C. S. Brown, I. Solodin, T. D. Heath, and R. J. Debs. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nature Biotechnol. 15:167-173 (1997).
14. L. G. Barron, L. S. Uyechi, and F. C. J. Szoka. Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes. Gene Ther. 6:1179-1183 (1999).
15. L. C. Mounkes, W. Zhong, G. Cipres-Palacin, T. D. Heath, and R. J. Debs. Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. J. Biol. Chem. 273: 26164-26170 (1998).
16. L. G. Barron, L. Gagne, and F. C. J. Szoka. Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration. Hum. Gene Ther. 10:1683-1694 (1999).
17. R. I. Mahato, K. Anwer, F. Tagliaferri, C. Meaney, P. Leonard, M. S. Wadhwa, M. Logan, M. French, and A. Rolland. Biodistribution and gene expression of lipid/plasmid complexes after systemic administration. Hum. Gene Ther. 9:2083-2099 (1998).
18. S. Li, S.-P. Wu, M. Whitmore, E. J. Loeffert, L. Wang, S. C. Watkins, B. R. Pitt, L. Huang. Effect of immune response on gene transfer to the lung via systemic administration of cationic lipid vectors. Am. J. Physiol. 276:L796-L804 (1999).
19. L. Mohr, S. K. Yoon, S. J. Eastman, Q. Chu, R. K. Scheule, P. P. Scaglioni, M. Geissler, T. Heintges, H. E. Blum, and J. R. Wands. Cationic liposome-mediated gene delivery to the liver and hepatocellular carcinomas in mice. Hum. Gene Ther. 12:799-809 (2001).
20. T. Nomura, S. Nakajima, K. Kawabata, F. Yamashita, Y. Takakura, and M. Hashida. Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer. Cancer Res. 57: 2681-2686 (1997).
21. T. Nomura, K. Yasuda, T. Yamada, S. Okamoto, R. I. Mahato, Y. Watanabe, Y. Takakura, and M. Hashida. Gene expression and antitumor effects following direct interferon (IFN)-γ, gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice. Gene Ther. 6:121-129 (1999).
22. P. R. Clark, A. T. Stopeck, M. Ferrari, S. E. Parker, and E. M. Hersh. Studies of direct intratumoral gene transfer using cationic lipid-complexed plasmid DNA. Cancer Gene Ther. 7:853-860 (2000).
23. P. R. Clark, A. T. Stopeck, S. E. Parker, and E. M. Hersh. Cationic lipid gene transfer of an IL-2 transgene leads to activation of natural killer cells in a SCID mouse human tumor xenograft. Cell. Immunol. 204:96-104 (2000).
24. N. Yerushalmi, U. Brinkmann, E. Brinkmann, L. Pai, and I. Pastan. Attenuating the growth of tumors by intratumoral administration of DNA encoding Pseudomonas exotoxin via cationic liposomes. Cancer Gene Ther. 7:91-96 (2000).
25. N. K. Egilmez, R. Cuenca, S. J. Yokota, F. Sorgi, and R. B. Bankert. In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery. Gene Ther. 3:607-614 (1996).
26. S. E. Parker, S. Khatibi, M. Margalith, D. Anderson, M. Yankauckas, S. H. Gromkowski, T. Latimer, D. Lew, M. Marquet, M. Manthorpe, P. Hobart, E. Hersh, A. T. Stopeck, and J. Norman. Plasmid DNA gene therapy: Studies with the human interleukin-2 gene into tumor cells in vitro and in the murine B16 melanoma model in vivo. Cancer Gene Ther. 3:175-185 (1996).
27. E. Galanis, E. M. Hersh, A. T. Stopeck, R. Gonzales, P. Burch, C. Spier, E. T. Akporiaye, J. J. Rinehart, J. Edmonson, R. E. Sobol, C. Forscher, V. K. Sondak, B. D. Lewis, E. C. Unger, M. O'Driscoll, L. Selk, and J. Rubin. Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: Phase I/II experience. J. Clin. Oncol. 17:3313-3323 (1999).
28. S. J. Eastman, M. J. Lukason, J. D. Tousignant, H. Murray, M. D. Lane, J. A. St. George, G. Y. Akita, M. Cherry, S. H. Cheng, and R. K. Scheule. A concentrated and stable aerosol formulation of cationic lipid:DNA complexes giving high-level gene expression in mouse lung. Hum. Gene Ther. 8:765-773 (1997).
29. J. E. Duncan, J. A. Whitsett, and D. Horowitz. Pulmonary surfactant inhibits cationic liposome-mediated gene delivery to respiratory epithelial cells in vitro. Hum. Gene Ther. 8:431-438 (1997).
30. U. Griesenbach, A. Chonn, R. Cassady, V. Hannam, C. Ackerley, M. Post, A. K. Tanswel, K. Olek, H. O'Brodovich, and L.-C. Tsui. Comparison between intratracheal and intravenous administration of liposome-DNA complexes for cystic fibrosis lung gene therapy. Gene Ther. 5:181-188 (1998).
31. S. C. Hyde, D. R. Gill, C. F. Higgins, A. E. O. Trezise, L. J. MacVinish, A. W. Cuthbert, R. Ratcliff, M. J. Evans, and W. H. Colledge. Correction of the ion transport, defect in cystic fibrosis mice by gene therapy. Nature 362:250-255 (1993).
32. D. J. Porteous, J. R. Dorin, G. McLachlan, H. Davidson-Smith, H. Davidson, B. J. Stevenson, A. D. Carothers, W. A. Wallace, S. Moralee, C. Hoenes, G. Kallmeyer, U. Michaelis, K. Naujoks, L. P. Ho, J. M. Samways, M. Imrie, A. P. Greening, and J. A. Innes. Evidence for safety and efficacy of DOTAP cationic liposome mediated CRTF gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 4:210-218 (1997).
33. E. W. Alton, M. Stern, R. Farley, A. Jaffe, S. L. Chadwick, J. Phillips, M. G. Davies, M. E. Hodson, S. R. Durham, D. Li, P. K. Jeffery, M. Scallan, R. Balfour, S. J. Eastman, S. H. Cheng, A. E. Smith, D. Meeker, and D. M. Geddes. Cationic lipid-mediated CRTF gene transfer to the lungs and nose of patients with cystic fibrosis: A double-blind placebo-controlled trial. Lancet 253:947-954 (1999).
34. E. S. Scott, J. W. Wiseman, M. J. Evans, and W. H. Colledge. Enhanced gene delivery to human airway epithelial cells using an integrin-targeting lipoplex. J. Gene Med. 3:125-134 (2001).
35. K. L. Brigham, K. B. Lane, B. Meyrick, A. A. Stecenko, S. Strack, D. R. Cannon, M. Caudill, and A. E. Canonico. Transfection of nasal mucosa with a normal alpha1-antitrypsin gene in alpha1-antitrypsin deficent subjects: Comparison with protein therapy. Hum. Gene Ther. 11:1023-1032 (2000).
36. J. Hartikka, V. Bozoukova, M. Ferrari, L. Sukhu, J. Enas, M. Sawdey, M. K. Wloch, K. Tonsky, J. Norman, M. Manthorpe, and C. J. Wheeler. Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens. Vaccine 19:1911-1923 (2001).
37. Y. Perrie, P. M. Frederik, and G. Gregoriadis. Liposome-mediated DNA vaccination: The effect of vesicle composition. Vaccine 19:3301-3310 (2001).
38. L. S. Klavinskis, C. Barnfield, L. Gao, and S. Parker. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts. J. Immunol. 162:254-262 (1999).
39. J. D. Toussignant, A. L. Gates, L. A. Ingram, C. L. Johnson, J. B. Nietupski, S. H. Chen, S. J. Eastman, and R. K. Scheule. Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice. Hum. Gene Ther. 11:2493-2513 (2000).
40. S. Loisel, C. Le Gall, L. Doucet, C. Ferec, and V. Floch. Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes. Hum. Gene Ther. 12:685-696 (2001).
41. S. Dokka, D. Toledo, X. Shi, V. Castranova, and Y. Rojanasakul. Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes. Pharm. Res. 17:521-525 (2000).
42. F. E. Ruiz, J. P. Clancy, M. A. Perricone, Z. Bebok, J. S. Hong, S. H. Cheng, D. P. Meeker, K. R. Young, R. A. Schoumacher, M. R. Weatherly, L. Wing, J. E. Morris, L. Sindel, M. Rosenberg, F. W. van Ginkel, J. R. McGhee, D. Kelly, R. K. Lyrene, and E. J. Sorscher. A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. Hum. Gene Ther. 12:751-761 (2001).
43. R. de Kanter, M. Monshouwer, D. K. Meijer, and G. M. Groothuis. Precision-cut organ slices as a tool to study toxicity and metabolism of xenobiotics with special reference to non-hepatic tissues. Curr. Drug Metab. 1:39-59 (2002).
44. R. K. Scheule, J. A. St. George, R. G. Bagley, J. Marshall, J. M. Kaplan, G. Y. Akita, K. X. Wang, E. R. Lee, D. J. Harris, C. Jiang, N. S. Yew, A. E. Smith, and S. H. Cheng. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum. Gene Ther. 8:689-707 (1997).
45. J. L. Bramson, C. A. Bodner, and R. W. Graham. Activation of host antitumoral responses by cationic lipid/DNA complexes. Cancer Gene Ther. 7:353-359 (2000).
46. M. Whitmore, S. Li, and L. Huang. LPD lipoplexes initiates a potent cytokine response and inhibits tumor growth. Gene Ther. 6:1867-1875 (1999).
47. S. W. Dow, R. E. Elmslie, L. G. Fradkin, D. H. Liggit, T. D. Heath, A. P. Willson, and T. A. Potter. Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases. Hum. Gene Ther. 10:2961-2972 (1999).
48. B. D. Freimark, H. P. Blezinger, V. J. Florack, J. L. Nordstrom, S. D. Long, D. S. Deshpande, S. Nochumson, and K. L. Petrak. Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid:cationic lipid complexes. J. Immunol. 160:4580-4586 (1998).
49. A. Gautman, C. L. Densmore, and J. C. Waldrep. Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy. Gene Ther. 8:254-257 (2001).
50. G. J. Weiner. The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides. J. Leukocyte Biol. 68:455-463 (2000).
51. J. Norman, W. Denham, D. Denham, J. Yang, G. Carter, A. Abouhamze, C. L. Tannahill, S. L. MacKay, and L. L. Moldawer. Liposome-mediated, nonviral gene transfer induces a systemic inflammatory response which can exacerbate pre-existing inflammation. Gene Ther. 7:1425-1430 (2000).
52. J. E. Baatz, Y. Zou, and T. R. Korfhagen. Inhibitory effects of tumor necrosis factor-α on cationic lipid-mediated gene delivery to airway cells in vitro. Biochim. Biophys. Acta 1535:100-109 (2001).
53. L. Qin, Y. Ding, D. R. Pahud, E. Chang, M. J. Imperiale, and J. S. Bromberg. Promoter attenuation in gene therapy: Interferon-γ and tumor necrosis factor-α inhibit transgene expression. Hum. Gene Ther. 8:2019-2029 (1997).
54. Y. Tan, F. Liu, Z. Li, S. Li, and L. Huang. Sequential injection of cationic liposome and plasmid DNA effectively transfects the lung with minimal inflammatory toxicity. Mol. Ther. 3:673-682 (2001).
55. S. W. Dow, L. G. Fradkin, D. H. Liggitt, A. P. Willson, T. D. Heath, and T. A. Potter. Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously. J. Immunol. 163:1552-1561 (1999).
56. Y. Liu, A. Thor, E. Shtivelman, Y. Cao, G. Tu, T. D. Heath, and R. J. Debs. Systemic gene delivery expands the repertoire of effective antiangiogenic agents. J. Biol. Chem. 274:13338-13344 (1999).
57. A. Natsume, M. Mizuno, Y. Ryuke, and J. Yoshida. Antitumor effect and cellular immunity activation by murine interferon-β gene transfer against intracerebral glioma in mouse. Gene Ther. 6:1626-1633 (1999).